Member Info for sphinx100

FFS Colby it’s 9 o’clock do you do any work you lazy git.

The Company's Fruitflow+ Omega-3 direct selling business has been operating largely as normal throughout the pandemic, and despite some initial delays in the supply chain a new production run of Fruitflow+ Omega-3 capsules has just been completed thus ensuring continued supply of the product.



The Company will issue a full trading update in due course.

Surprised we’re going to get a trading update !must be something of interest to tell us .

Pumpky It’s the monetary value £17.49 doh !

But not before I buy my final 1m please mms

After the last purchase by SL sp wen from about .85 p to over 1p , let’s hope for the same this week ! https://www.lse.co.uk/ShareChart.asp?sharechart=PXS&share=Provexis

I wouldn’t worry about that ,with most patents running until 2033 pxs won’t exist by then it will be long gone as most of the long termers who have held for many years .

SIte updated https://www.provexis.org/shareholder-information/major-shareholders/

WS all a bit clandestine , could be they didn’t want sp to rise today , imo there could be some news on Monday .

Requirement for a mandatory offer: Where a bidder is interested in shares carrying 30% or more of the target’s voting share rights, the bidder must make a mandatory offer in cash at no less than the highest price paid during the preceding 12 months (often referred to as a "Rule 9 offer"). Mandatory offers can only be conditional on the bidder receiving acceptances that, together with any shares already held or acquired during the offer, would give the bidder and its concert parties more than 50% of the voting rights. As such, bidders cannot rely on other conditions to protect themselves.“

We know there are 9 studies being carried out through By health ,I believe 7 were completed ,I would think all were now complete , though I couldn’t say for certain , we don’t know what those studies involved , only ff + nitrates has been disclosed , we all await the Blue hat approval announcement !

Hi sock , yes all profits from ff sales (except ff+omega3) are split between DSM and Pxs , nobody knows what the split is as it is confidential , there are many studies going on besides the research that By health are doing .

Dated 6th Aug 2020. A study of Laura’s Noblis (bayleaf) and other substances including ff , to protect against the effects of air pollution and related diseases (including cancer)
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020156908&tab=PCTCLAIMS&_cid=P20-KDJMUB-36194-2

All reaffirmed today https://www.dsm.com/corporate/searchresults.html?mcvid=38293847620420050163354013310388942060&query=Fruitflow&languageCode=en&siteName=corporate

Still strongly supporting ff. https://www.dsm.com/corporate/news/news-archive/2019/insights-dsm-sport-our-race-never-ends.html

This is the reality check , Stuart Lucas was senior MD of Bear Stearns for 6 years , MD of Prudential for 5 years ,MD of Nomura for 4 years ,before starting the highly successful Asset Match , he has invested over £500k in this company. Now who would you want to follow Mr Lucas or a trader who try’s to make 20quid on a 50. Quid punt , I know where my money is staying .!

It was Stuart Lucas and the shareholder register shows he hasn’t sold any , that’s your theories blown out of the water !

The market certainly seemed to like it , sp on new year high !

“On the evening of July 29, Byhealth Co., Ltd. (300146.SZ, hereinafter referred to as "Byhealth" or "the Company") disclosed the 2020 semi-annual performance report. According to the report, the Company's operating revenue from January to June this year was 3.125 billion Yuan, a year-on-year increase of 5.23%, and the net profit attributable to shareholders of listed company was 962 million Yuan, a year-on-year increase of 10.96%. As a global leader in Vitamin & Dietary Supplements (VDS), Byhealth has overcome several external adverse factors, shown steady momentum and sustained growth in the 2020 semi-annual examination.”

Since the outbreak of COVID-19, the domestic consumer market has been impacted to varying degrees. As Byhealth stated in the report, due to the pandemic, the Company's production, marketing, and new product launch in the first half of the year have been delayed compared to the normal schedule, and the off-line business of the Company has also been affected to a certain extent. In the first half of the year, the Company's domestic off-line channel revenue fell by 4.35% year-on-year, while on-line business achieved rapid growth, with domestic on-line channel revenue increased by 46.83% year-on-year. Despite the global spread of the COVID-19 and the existence of repeated outbreak in Australia, the development of cross-border e-commerce platforms has brought new impetus to the business growth of LSG in Australia. In the first half of the year, LSG's overseas business achieved operating income of A$66 million, a year-on-year increase of 16.74%, and a year-on-year increase of 30.73% after the inter-segment offset. “

Looks like shares were suspended after the rise https://www.bloomberg.com/quote/300146:CH